M&T Bank Corp Neurocrine Biosciences Inc Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, M&T Bank Corp holds 5,998 shares of NBIX stock, worth $752,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,998

Previous 6,187 3.05%

Holding current value

$752,808

Previous $853,000 3.28%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$130.86 - $143.19 $24,732 - $27,062	-189 Reduced 3.05%	5,998 $825,000
Q1 2024 May 07, 2024	SELL	$130.4 - $143.74 $77,848 - $85,812	-597 Reduced 8.8%	6,187 $853,000
Q4 2023 Feb 06, 2024	SELL	$106.07 - $132.76 $46,989 - $58,812	-443 Reduced 6.13%	6,784 $893,000
Q3 2023 Nov 02, 2023	SELL	$94.02 - $117.1 $260,247 - $324,132	-2,768 Reduced 27.69%	7,227 $813,000
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $44,406 - $52,015	-496 Reduced 4.73%	9,995 $942,000
Q1 2023 May 11, 2023	SELL	$94.11 - $123.02 $111,426 - $145,655	-1,184 Reduced 10.14%	10,491 $1.06 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $570,311 - $679,008	5,344 Added 52.67%	15,490 $1.85 Million
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $407,136 - $484,733	-3,815 Reduced 24.63%	11,675 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $363,794 - $426,172	-3,953 Reduced 28.04%	10,146 $1.03 Million
Q2 2022 Aug 05, 2022	BUY	$75.79 - $100.07 $868,250 - $1.15 Million	11,456 Added 433.45%	14,099 $294,000
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $6,665 - $8,722	92 Added 3.61%	2,643 $248,000
Q4 2021 Feb 07, 2022	SELL	$79.65 - $106.22 $23,417 - $31,228	-294 Reduced 10.33%	2,551 $218,000
Q3 2021 Oct 28, 2021	SELL	$86.18 - $99.03 $430 - $495	-5 Reduced 0.18%	2,845 $274,000
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $804 - $920	9 Added 0.32%	2,850 $278,000
Q1 2021 May 06, 2021	SELL	$87.57 - $119.4 $14,273 - $19,462	-163 Reduced 5.43%	2,841 $277,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $3,910 - $4,874	-45 Reduced 1.48%	3,004 $289,000
Q3 2020 Nov 06, 2020	BUY	$96.16 - $135.15 $16,635 - $23,380	173 Added 6.02%	3,049 $294,000
Q2 2020 Jul 29, 2020	SELL	$85.09 - $130.36 $42,204 - $64,658	-496 Reduced 14.71%	2,876 $351,000
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $4,431 - $6,711	59 Added 1.78%	3,372 $291,000
Q4 2019 Feb 07, 2020	SELL	$86.8 - $118.57 $14,582 - $19,919	-168 Reduced 4.83%	3,313 $355,000
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $8,717 - $10,556	104 Added 3.08%	3,481 $313,000
Q2 2019 Aug 12, 2019	BUY	$72.24 - $91.27 $11,052 - $13,964	153 Added 4.75%	3,377 $286,000
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $16,079 - $21,234	232 Added 7.75%	3,224 $285,000
Q4 2018 Feb 01, 2019	SELL	$68.32 - $124.36 $6,490 - $11,814	-95 Reduced 3.08%	2,992 $214,000
Q3 2018 Nov 09, 2018	BUY	$98.88 - $125.85 $24,522 - $31,210	248 Added 8.74%	3,087 $380,000
Q2 2018 Aug 10, 2018	BUY	$75.3 - $105.99 $978 - $1,377	13 Added 0.46%	2,839 $278,000
Q1 2018 May 04, 2018	BUY	$75.88 - $92.43 $16,617 - $20,242	219 Added 8.4%	2,826 $235,000
Q4 2017 Feb 06, 2018	BUY	$58.53 - $77.59 $152,587 - $202,277	2,607	2,607 $202,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account